UBS Group
UROY

UBS Group’s Uranium Royalty Corp UROY Stock Holding History

UBS Group’s Portfolio UROY Stock Details UROY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
302,734
-103,959
-26% -$425K ﹤0.01% 5477
2025
Q4 		$1.44M Sell
406,693
-389,632
-49% -$1.52M ﹤0.01% 5255
2025
Q3 		$3.42M Buy
796,325
+19,604
+3% +$59.3K ﹤0.01% 4431
2025
Q2 		$1.94M Sell
776,721
-84,645
-10% -$171K ﹤0.01% 4855
2025
Q1 		$1.52M Buy
861,366
+59,007
+7% +$126K ﹤0.01% 4925
2024
Q4 		$1.76M Buy
802,359
+341,316
+74% +$877K ﹤0.01% 4842
2024
Q3 		$1.13M Buy
461,043
+19,607
+4% +$44.2K ﹤0.01% 4555
2024
Q2 		$993K Buy
441,436
+108,609
+33% +$270K ﹤0.01% 4430
2024
Q1 		$795K Buy
332,827
+21,824
+7% +$62K ﹤0.01% 4782
2023
Q4 		$840K Buy
311,003
+172,966
+125% +$485K ﹤0.01% 4656
2023
Q3 		$396K Buy
138,037
+28,972
+27% +$68.2K ﹤0.01% 4842
2023
Q2 		$218K Buy
109,065
+3,562
+3% +$7.09K ﹤0.01% 5417
2023
Q1 		$217K Buy
105,503
+1,088
+1% +$2.6K ﹤0.01% 5324
2022
Q4 		$247K Sell
104,415
-2,820
-3% -$6.87K ﹤0.01% 5288
2022
Q3 		$240K Sell
107,235
-60,478
-36% -$159K ﹤0.01% 4928
2022
Q2 		$381K Buy
167,713
+71,386
+74% +$229K ﹤0.01% 4467
2022
Q1 		$379K Sell
96,327
-1,351
-1% -$5.13K ﹤0.01% 4891
2021
Q4 		$357K Buy
97,678
+33,027
+51% +$151K ﹤0.01% 5250
2021
Q3 		$233K Buy
64,651
+1,313
+2% +$4.03K ﹤0.01% 5204
2021
Q2 		$190K Buy
+63,338
New +$189K ﹤0.01% 5391

Other funds holding UROY

Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's UROY Position: Q1 2026 in Review

UBS Group reduced its Uranium Royalty Corp (UROY) stake by 26% in Q1 2026, selling an estimated $425K and leaving 302,734 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #5477.

UBS Group first reported a position in UROY in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.42M in Q3 2025. 108 funds tracked by Wall St. Rank hold UROY as of Q1 2026.

  • UBS Group held 302,734 shares of Uranium Royalty Corp worth $1.1M as of Q1 2026.
  • UBS Group sold 103,959 Uranium Royalty Corp shares in Q1 2026, an estimated $425K.
  • Uranium Royalty Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5477 holding.
  • UBS Group first reported a position in Uranium Royalty Corp in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Uranium Royalty Corp position peaked at $3.42M in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.